Ziconotide N-type neuronal calcium channel blocker regulatory update

ELN received an approval letter from the FDA for its ziconotide to treat severe chronic pain via intrathecal administration. ELN acquired ziconotide through its purchase of Neurex Corp. in 1998. ...